Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$58,404,972
-$3,021,332 QoQ
Shares Held
229,968
-8.5% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
2.50%
of 13F equity value
Holder Rank
#412
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ancora Advisors LLC holds $96,816,715 across 11 Drug Manufacturers - General names. JNJ ranks #1 (60.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
229,968 | $58,404,972 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
121,465 | $15,345,887 | |
| 3 | AMGN |
Amgen Inc
|
34,637 | $12,542,749 | |
| 4 | LLY |
ELI LILLY & Co
|
3,182 | $3,816,586 | |
| 5 | MRK |
Merck & Co., Inc.
|
20,902 | $2,685,906 | |
| 6 | PFE |
Pfizer Inc
|
88,780 | $2,137,822 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,068 | $1,386,797 | |
| 8 | NVS |
Novartis AG
|
2,086 | $326,917 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,404,972 | 229,968 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $61,426,304 | 251,294 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $57,322,459 | 276,987 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $51,157,748 | 275,902 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $40,255,887 | 263,541 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $43,455,717 | 262,034 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $37,702,288 | 260,699 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $43,685,865 | 269,566 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $41,391,634 | 283,194 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $44,484,134 | 281,207 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $47,009,773 | 299,922 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $47,698,125 | 306,248 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $52,039,653 | 314,401 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $48,083,635 | 310,217 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $53,746,998 | 304,257 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $44,645,960 | 273,298 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $47,842,494 | 269,520 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $47,079,908 | 265,643 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $46,691,332 | 272,937 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $43,177,671 | 267,354 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $42,534,549 | 258,192 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $43,333,506 | 263,666 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $40,496,391 | 257,316 | Shares | Sole | 2021-11-12 | |
| 2020-09-30 | $37,916,906 | 254,681 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $34,708,045 | 246,804 | Shares | Sole | 2021-11-12 | |
| 2020-03-31 | $31,975,001 | 243,842 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||